GPT and neutropenia: Moreover, higher frequency of hematologic AEs (especially neutropenia and thrombocytopenia), ALT and/or AST elevated, nausea, and vomiting were discovered in HAIC-combined therapy compared to targeted and/or anti-PD-1 mAb therapy.